{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:07:12Z","timestamp":1782349632557,"version":"3.54.5"},"reference-count":25,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>People living with HIV (PLWH) aged \u2265 50\u00a0years face unique challenges regarding their medication therapies, especially antiretroviral therapy (ART). Use of ARTs, along with medications for comorbidities, may lead to adverse events, drug\u2013drug interactions (DDIs) and poor adherence. The objective of this study was to identify the number of medications above which PLWH aged \u2265 50 years are less likely to be virally suppressed and to describe other associated patient\u2010specific risk factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a cross\u2010sectional study of PLWH aged \u2265 50\u00a0years, prescribed ART, and seen at least once in the Northwestern Infectious Disease Center between 1 June 2013 and 31 May 2015. Variables concerning medication use and comorbidities were collected. The primary outcome was the presence of an undetectable plasma HIV RNA level (viral load).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 621 included patients, there was a higher percentage taking \u2264\u00a015 medications with an undetectable plasma HIV RNA (<jats:italic>n<\/jats:italic>\u00a0=\u00a0453; 80.6%) <jats:italic>vs<\/jats:italic>. patients taking &gt;\u00a015 medications (<jats:italic>n<\/jats:italic>\u00a0=\u00a040; 67.8%; <jats:italic>P<\/jats:italic>\u00a0=\u00a00.03). Taking &gt;\u00a015 medications [odds ratio (OR) 0.49; 95% confidence interval (CI) 0.26\u20130.96], pulmonary disease (OR 0.54; 95% CI 0.3\u20130.97) and CD4 T\u2010lymphocyte count &lt;\u00a0200 cells\/\u03bcL (OR 0.39; 95% CI 0.22\u20130.68) decreased the odds of having an undetectable plasma HIV RNA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>PLWH taking &gt;\u00a015 medications were less likely to have an undetectable HIV RNA. Further studies are needed to evaluate the impact of overall medication economic burden on clinical outcomes among PLWH \u2265\u00a050\u00a0years of age.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hiv.13122","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T21:48:17Z","timestamp":1622670497000},"page":"742-749","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Relationship of polypharmacy to HIV RNA suppression in people aged \u2265 50 years living with HIV"],"prefix":"10.1111","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8748-185X","authenticated-orcid":false,"given":"MM","family":"Murray","sequence":"first","affiliation":[{"name":"Midwestern University College of Pharmacy Downers Grove Campus Downers Grove IL USA"},{"name":"Northwestern Memorial Hospital Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lin","sequence":"additional","affiliation":[{"name":"Midwestern University College of Pharmacy Downers Grove Campus Downers Grove IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Buros Stein","sequence":"additional","affiliation":[{"name":"Midwestern University Office of Research and Sponsored Programs Glendale AZ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ML","family":"Wilcox","sequence":"additional","affiliation":[{"name":"Northwestern Memorial Hospital Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Cottreau","sequence":"additional","affiliation":[{"name":"Rosalind Franklin University of Medicine and Science North Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Postelnick","sequence":"additional","affiliation":[{"name":"Northwestern Memorial Hospital Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FJ","family":"Palella","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Northwestern University Feinberg School of Medicine Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,6,2]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00056-0"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000615"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0201-6"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2009.00750.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104945"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1179\/1528433614Z.0000000012"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix998"},{"key":"e_1_2_8_10_1","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents.Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services. Available athttp:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/AdultandAdolescentGL.pdf(accessed 9 August 2020)."},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr248"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25449"},{"key":"e_1_2_8_13_1","first-page":"251","article-title":"Management of HIV\/AIDS in older patients\u2010drug\/drug interactions and adherence to antiretroviral therapy","volume":"7","author":"Burgess MJ","year":"2015","journal-title":"HIV AIDS (Auckl)"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002349"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000305"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir626"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028013504075"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.12695"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.25100\/cm.v50i3.4128"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2019.0069"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz531"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S108072"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2043"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-019-02785-z"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00876-0"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002372"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.13122","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hiv.13122","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.13122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T19:41:33Z","timestamp":1693338093000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.13122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,2]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1111\/hiv.13122"],"URL":"https:\/\/doi.org\/10.1111\/hiv.13122","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,2]]},"assertion":[{"value":"2021-01-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}